阿齐思罗米的大规模药物管理试验:为未来研究和指导方针提供信息的分析
Alex C Kong1, Anthony D So2,3
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. alex.cy.kong@gmail.com.
Infectious diseases of poverty
|July 21, 2025
概括
随着阿齐思罗米的大量药物管理,显示了降低儿童死亡率的好处,但需要进一步的研究来优化其使用和监测抗菌素耐药性 (AMR). 长期研究将为这项公共卫生干预提供未来指导方针.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 公共卫生干预 公共卫生干预
背景情况:
- 世界卫生组织 (WHO) 在2020年发布了关于大规模药物管理 (MDA) 的指南,以减少儿童死亡率.
- 扩大MDA-阿齐思罗米需要仔细考虑,以最大限度地提高益处并减轻抗菌素耐药性 (AMR) 等风险.
- 集群随机试验提供了关于MDA-亚胺素的益处和风险的关键证据,并确定了监测和解决知识差距的做法.
研究的目的:
- 检查阿齐思罗米MDA的临床试验趋势,证据和知识差距.
- 为了确定与向,终点,共同干预,溢出效应和AMR监测相关的实践.
- 为未来的研究和MDA-阿兹罗米辛干预的指导方针提供信息.
主要方法:
- 在clinicaltrials.gov和世卫组织ICTRP (开始至2023年12月31日) 注册的阿齐思罗米临床试验的系统审查.
- 纳入标准侧重于使用阿齐思罗米用于非特异性疾病预防/治疗的试验,具有地理随机化治疗臂.
- 在五个领域进行分析:向,临床终点,联合干预,溢出和AMR监测.
主要成果:
- 30项试验符合纳入标准,主要是在撒哈拉以南非洲 (26/30).
- 死亡终点在近三分之一的试验中被纳入 (9/30),很少有人指定特定原因的死亡率 (2/9).
- 有证据表明,更广泛地针对年龄和坚持竞争性干预措施有好处;为了减少溢出效应,地理隔离并不常见. 仅有超过一半的试验 (16/30) 提供了AMR监测数据,使用了各种测试方法.
结论:
- 进一步的长期研究有价值,以确定额外的受益国家和最佳的辅助干预措施.
- 调查AMR溢出影响的程度对于修订MDA-阿兹胺指南至关重要.
- 研究应集中在伴随或替代阿齐思罗米辛MDA的干预措施和全面的AMR监测上.
相关概念视频
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
177
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
177
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
01:26Drug Administration and Therapy Phases: Overview
761
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
761